102 Assessing reasons for patients switching back from...

Rheumatology 2019 / 04 Vol. 58; Iss. Supplement

102 Assessing reasons for patients switching back from biosimilar etanercept therapy to originator product

Dahanayake, Chanaka, Shah, Kavina, Al-Abdulla, Ahmad, Carulli, Maresa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
58
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/kez108.010
Date:
April, 2019
File:
PDF, 58 KB
english, 2019
Conversion to is in progress
Conversion to is failed